The Role of Health Technology Assessment in Medicine Pricing and Reimbursement
This policy brief summarises the key points from the review on the role of health technology assessment (HTA) in medicine pricing and reimbursement with a focus on its use in low- and middle-income countries (LMICs).
Sign Up to start bookmarking content
United Nations World Food Programme
Global Alliance for Chronic Diseases
World Health Organization